In this issue introduced by Fabrice André (Institut Gustave Roussy, Villejuif, France), leading researchers exchange their views about the potential role of immunotherapies in breast cancer and our current understanding of the immune response to this disease. In addition, an interview of Prof. Gabriel N. Hortobagyi (The University of Texas MD Anderson Cancer Center, USA) gives insight into the trans-Atlantic efforts aiming to move the field of immunotherapies forward faster. We hope you will enjoy the reading.
GBG Forschungs GmbH
Martin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440